San Francisco, CA, United States of America

Amy E Kable


Average Co-Inventor Count = 21.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amy E Kable: Innovator in Immunology

Introduction

Amy E Kable is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of immunology, particularly through her innovative research and patents. Her work focuses on the development of human receptors and membrane-associated proteins that play a crucial role in immune responses.

Latest Patents

Amy E Kable holds a patent for a CD40-related receptor that binds CD40L. This invention encompasses various embodiments that provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides, which identify and encode REMAP. Additionally, her patent includes expression vectors, host cells, antibodies, agonists, and antagonists. The invention also outlines methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP. She has 1 patent to her name.

Career Highlights

Amy is currently employed at Incyte Corporation, where she continues to advance her research in immunology. Her work at Incyte has allowed her to collaborate with other leading scientists in the field, contributing to groundbreaking advancements in medical science.

Collaborations

Some of her notable coworkers include Narinder K Chawla and Henry Yue. Their collaborative efforts have further enhanced the research and development of innovative solutions in immunology.

Conclusion

Amy E Kable is a remarkable inventor whose work has the potential to impact the diagnosis and treatment of various immune-related disorders. Her contributions to the field of immunology are invaluable, and her ongoing research promises to lead to further advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…